This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adamo, J. E.
Right arrow Articles by Ye, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adamo, J. E.
Right arrow Articles by Ye, Z.

 Previous Article  |  Next Article 

Journal of Virology, May 2009, p. 4023-4029, Vol. 83, No. 9
0022-538X/09/$08.00+0     doi:10.1128/JVI.02391-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Optimizing Viral Protein Yield of Influenza Virus Strain A/Vietnam/1203/2004 by Modification of the Neuraminidase Gene{triangledown}

Joan E. Adamo, Teresa Liu, Falko Schmeisser, and Zhiping Ye*

Division of Viral Products, CBER, U.S. Food and Drug Administration, Bethesda, Maryland 20892

Received 18 November 2008/ Accepted 3 February 2009

The preparation of high-yield prepandemic influenza virus H5N1 strains has presented a challenge to both researchers and vaccine manufacturers. The reasons for the relatively low yield of the H5N1 strains are not fully understood, but it might be partially dependent on the interactions between the hemagglutinin (HA) or neuraminidase (NA) surface glycoprotein and other influenza virus proteins. In this study, we have constructed chimeras between the A/Puerto Rico/8/34 (PR8) NA gene and the A/Vietnam/1203/2004 (VN1203) NA gene that have resulted in an increase in the virus yield of the reassortant viruses without a significant loss of NA activity. By combining the amino terminus of NA from the PR8 strain with the carboxy terminus of NA from VN1203, the surface epitopes unique to the H5N1 VN1203 NA glycoprotein are maintained. This reassortant virus had a higher titer and total protein yield in eggs, grew to a higher titer, produced large plaques on MDCK cells, and retained NA activity. This work describes a novel recombinant technique designed to increase the yields of vaccine candidates for the production of pandemic influenza virus vaccines. The relationship between the infectivity and protein yield of the reassortants also is discussed.

* Corresponding author. Mailing address: Division of Viral Products, CBER, U.S. Food and Drug Administration, 29A/1B11, 8800 Rockville Pike, Bethesda, MD 20892. Phone: (301) 435-5197. Fax: (301) 480-3157. E-mail: zhiping.ye{at}fda.hhs.gov

{triangledown} Published ahead of print on 18 February 2009.

Journal of Virology, May 2009, p. 4023-4029, Vol. 83, No. 9
0022-538X/09/$08.00+0     doi:10.1128/JVI.02391-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»